Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: Deficiency of an aspirin-independent mechanism?

P. Viero, S. Cortelazzo, T. Barbui, G. De Gaetano

Research output: Contribution to journalArticle

Abstract

Platelets from 6 out of 10 patients with myeloproliferative disorders showed only a single reversible wave of aggregation when challanged with platelet activating factor (PAF). Preexposure to subthreshold concentrations of adrenaline resulted in a full irreversible response to PAF. Aspirin, however, removed this synergism. In the remaining 4 patients, PAF induced a full response but aspirin abolished the synergism with adrenaline in 2 of them. In platelets from all controls aspirin failed to abolish the synergism between PAF and adrenaline. It is suggested that patients with myeloproliferative disorders lack - to varying degrees - and aspirin-independent mechanism wich amplifies the primary response to PAF. Such a mechanism could involve the products of arachidonic acid metabolism catalyzed by lipoxygenase.

Original languageEnglish
Pages (from-to)27-33
Number of pages7
JournalHaemostasis
Volume16
Issue number1
Publication statusPublished - 1986

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: Deficiency of an aspirin-independent mechanism?'. Together they form a unique fingerprint.

  • Cite this